Back
Fortress Biotech Quote, Financials, Valuation and Earnings
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
FBIO
Fortress Biotech
Last Price:
1.49
Seasonality Move:
-21.79%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Fortress Biotech Price Quote
$1.49
-0.35 (-19.02%)
(Updated: September 20, 2024 at 6:55 PM ET)
Fortress Biotech Key Stats
Sell
25
Fortress Biotech (FBIO)
is a Sell
Day range:
$1.82 - $2.00
52-week range:
$1.24 - $5.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.20
P/B ratio:
2.35%
Volume:
355.3K
Avg. volume:
239.6K
1-year change:
-62.83%
Market cap:
$42M
Revenue:
$84.5M
EPS:
$-13.45
How Much Does Fortress Biotech Make?
-
How Much Are Fortress Biotech's Sales Annually?
FBIO Revenues are $84.5M -
How Much Profit Does Fortress Biotech's Make A Year?
FBIO net income is -$60.6M
Is Fortress Biotech Growing As A Company?
-
What Is Fortress Biotech's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.14% -
What Is Fortress Biotech's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Fortress Biotech Stock Price Performance
-
Did Fortress Biotech Stock Go Up Last Month?
Fortress Biotech share price went down by -5.15% last month -
Did FBIO's Share Price Rise Over The Last Year?
FBIO share price fell by -62.83% over the past 1 year
What Is Fortress Biotech 52-Week High & Low?
-
What Is Fortress Biotech’s 52-Week High Share Price?
Fortress Biotech has traded as high as $5.25 over the past 52 weeks -
What Is Fortress Biotech’s 52-Week Low Share Price?
Fortress Biotech has traded as low as $1.24 over the past 52 weeks
Fortress Biotech Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Fortress Biotech?
-
How Much Debt Does Fortress Biotech Have?
Total long term debt quarterly is $70M -
How Much Cash Does Fortress Biotech Have?
Cash and short term investments quarterly total is $76.2M -
What Is Fortress Biotech’s Book Value Per Share?
Book value per share is 0.79
Is Fortress Biotech Cash Flow Positive?
-
What Is FBIO Cash Flow From Operations?
Cash flow from operations (TTM) is -$98.9M -
What Is Fortress Biotech’s Cash Flow From Financing?
Cash flow from financing (TTM) is $83.1M -
What Is Fortress Biotech’s Cash Flow From Investing?
Cash flow from investing (TTM) is $4.9M
Fortress Biotech Return On Invested Capital
-
Is Management Doing A Good Job?
FBIO return on invested capital is -78.24% -
What Is Fortress Biotech Return On Assets?
ROA measures how assets are converting to revenues and is -25.14% -
What Is FBIO Return On Equity?
ROE is a measure of profitability and is 0%
Fortress Biotech Earnings Date & Stock Price
-
What Is Fortress Biotech's Stock Price Today?
A single share of FBIO can be purchased today for 1.84 -
What Is Fortress Biotech’s Stock Symbol?
Fortress Biotech trades on the nasdaq under the ticker symbol: FBIO -
When Is Fortress Biotech’s Next Earnings Date?
The next quarterly earnings date for Fortress Biotech is scheduled on November 7, 2024 -
When Is FBIO's next ex-dividend date?
Fortress Biotech's next ex-dividend date is September 21, 2024 -
How To Buy Fortress Biotech Stock?
You can buy Fortress Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Fortress Biotech Competitors
-
Who Are Fortress Biotech's Competitors?
Below is a list of companies who compete with Fortress Biotech or are related in some way:
Fortress Biotech Dividend Yield
-
What Is FBIO Dividend Yield?
Fortress Biotech’s dividend yield currently is 0% -
What Is Fortress Biotech’s Payout Ratio?
Fortress Biotech’s payout ratio is -21.5% -
When Did Fortress Biotech Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Fortress Biotech’s Dividend Per Share?
Fortress Biotech pays a dividend of $0.00 per share
Fortress Biotech Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | -14.32% | 0.83% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 14.00 |
| Upside from Last Price: | 660.87% |